Robert J. Cardnell, Ph.D.

Affiliations: 
2006 Rice University, Houston, TX 
Area:
Drosophila Neuro-genetics
Google:
"Robert Cardnell"
Mean distance: 17.37 (cluster 6)
 
SNBCP

Parents

Sign in to add mentor
Michael Stern grad student 2006 Rice University
 (In vivo analysis of gain-of-function mutations in the Drosophila eag-encoded potassium ion channel.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Cardnell RJ, Feng Y, Mukherjee S, et al. (2016) Activation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung Cancer. Plos One. 11: e0152584
Mak M, Tong P, Diao L, et al. (2015) A patient-derived, pan-cancer EMT signature identifies global molecular alterations and immune target enrichment following epithelial to mesenchymal transition. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Cardnell RJ, Behrens C, Diao L, et al. (2015) An Integrated Molecular Analysis of Lung Adenocarcinomas Identifies Potential Therapeutic Targets among TTF1-Negative Tumors, Including DNA Repair Proteins and Nrf2. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research
Rabender CS, Alam A, Sundaresan G, et al. (2015) The Role of Nitric Oxide Synthase Uncoupling in Tumor Progression. Molecular Cancer Research : McR. 13: 1034-43
Cardnell RJ, Feng Y, Diao L, et al. (2013) Proteomic markers of DNA repair and PI3K pathway activation predict response to the PARP inhibitor BMN 673 in small cell lung cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 6322-8
Cardnell RJ, Rabender CS, Ross GR, et al. (2013) Sepiapterin ameliorates chemically induced murine colitis and azoxymethane-induced colon cancer. The Journal of Pharmacology and Experimental Therapeutics. 347: 117-25
Byers LA, Diao L, Wang J, et al. (2013) An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 279-90
Cardnell RJ, Nogare DE, Ganetzky B, et al. (2006) In vivo analysis of a gain-of-function mutation in the Drosophila eag-encoded K+ channel. Genetics. 172: 2351-8
See more...